Formycon AG
Liquid formulation of a VEGF antagonist
Last updated:
Abstract:
The present invention relates to liquid pharmaceutical compositions of a VEGF antagonist for intravitreal administration comprising a histidine buffer, an inorganic salt, a carbohydrate and a polysorbate.
Status:
Grant
Type:
Utility
Filling date:
26 Jan 2017
Issue date:
3 Mar 2020